Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2015

View Archived Issues

Yakult Honsha begins Japanese phase I study of resminostat for pancreatic or biliary tract cancer

BARDA exercises additional contract funding for AEOL-10150

[18F]PTV-F1 PET: imaging liver OATP transporter

New gene therapy shows safety and efficacy for the treatment of ADA deficiency

Invion completes dosing in phase II trial of oral INV-102 in smoking cessation

Cynapsus initiates phase III trial of AP-130277 for Parkinson's disease

Phase II trial of SYN-010 begins in irritable bowel syndrome with constipation

Phase III study of Emend meets endpoint in chemotherapy-induced nausea and vomiting

FibroGen receives license payment from AstraZeneca for roxadustat

Celgene and Juno establish 10-year global immunotherapy collaboration

Clinical activity seen with AM-0010 in first-in-human trial

McMaster University develops a novel model of cancer-induced depression

Stelara receives European approval for adolescents with moderate to severe psoriasis

Vitae initiates phase I study of VTP-43742 for autoimmune disorders

New biomarker identified for anti-EGFR therapy prognosis

Combination of durvalumab with dabrafenib and/or trametinib

Merck & Co. discloses orexin OX2 receptor antagonists

Daiichi Sankyo patents LCAT activators

Bayer Schering Pharma introduces sGC activators

JST patents Abeta aggregation inhibitors

Medshine Discovery presents anti-RSV agents

Telesta Therapeutics submits BLA to the FDA for MCNA

Bayer Yakuhin launches Gadovist intravenous injection 1.0 mol/L in Japan

MJFF and MSPRF Parkinson's research foundations to merge

FDA awards QIDP designation to Innocoll's gentamicin collagen matrix for diabetic foot infections

Expanded indication for Adenuric in Europe

FDA grants fast track status to Aerucin for hospital-acquired and ventilator-associated pneumonia

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...